Profound Medical (PROF) Cost of Revenue (2024 - 2026)

Profound Medical has reported Cost of Revenue for 3 years, with the latest figure at $536000.0 in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 9.61% year-over-year to $536000.0 in Q2 2026; TTM through Jun 2026 was $5.4 million, a 48.8% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 29.15% from the prior year.
• Cost of Revenue was $536000.0 for Q2 2026 at Profound Medical, down from $1.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.0 million in Q4 2025, with the low at $536000.0 in Q2 2026.
• Average Cost of Revenue over 3 years is $1.0 million, with a median of $928000.0 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue fell 26.97% in 2025, then jumped 95.96% in 2026.
• Over 3 years, Cost of Revenue stood at $1.2 million in 2024, then surged by 63.59% to $2.0 million in 2025, then slumped by 73.01% to $536000.0 in 2026.
• The last three Cost of Revenue figures came in at $536000.0 (Q2 2026), $1.5 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.